Atlas FDA

COBAS AMPLIPREP/COBAS TAQMAN HBV TEST

FDA premarket approval P050028/S004 · decided 2010-09-09

Approval details

PMA number
P050028
Supplement
S004
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
COBAS AMPLIPREP/COBAS TAQMAN HBV TEST
Generic name
Hepatitis Viral B DNA Detection
Applicant
Roche Molecular Systems, Inc.
Date received
2009-07-01
Decision date
2010-09-09
Days to decision
435 days
Decision code
APPR
Product code
MKT
Advisory committee
Microbiology
Expedited review
No
Location
Pleasanton, CA
Statement
APPROVAL FOR A DEVICE DESIGN MODIFICATION THAT INCLUDES REAGENTS, DISPOSABLES,AND INSTRUMENTATION, TO AUTOMATE THE MANUAL SAMPLE PREPARATION PROCESS CURRENTLY USED BY THE COBAS TAQMAN HBV TEST FOR USE WITH THE HIGH PURE SYSTEM. THE DEVICE, AS MODIFIED,WILL BE MARKETED UNDER THE TRADE NAME COBAS AMPLIPREP/ COBAS TAQMAN HBV TEST, V2.0AND IS INDICATED FOR:THE COBAS AMPLIPREP/COBAS TAQMAN HBV TEST, V2.0 IS AN IN VITRO NUCLEIC ACIDAMPLIFICATION LEST FOR THE QUANTITATION OF HEPATITIS B VIRUS (HBV) DNA

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
cobas® BV/CV (K260021)Roche Molecular Systems, Inc.2026-07-16
cobas CT/NG for use on the cobas 5800/6800/8800 systems; cobas TV/MG for use on the cobas 5800/6800/8800 systems (K260917)Roche Molecular Systems, Inc.2026-07-08
cobas liat CT/NG/MG nucleic acid test (K253759)Roche Molecular Systems, Inc.2026-05-15
cobas liat CT/NG nucleic acid test (K253756)Roche Molecular Systems, Inc.2026-05-15
cobas liat Bordetella panel nucleic acid test (K243753)Roche Molecular Systems, Inc.2025-11-20
cobas CMV (K252481)Roche Molecular Systems, Inc.2025-11-03
cobas HCV (K252484)Roche Molecular Systems, Inc.2025-11-03
cobas Respiratory 4-flex for use on the cobas 5800/6800/8800 Systems (K243455)Roche Molecular Systems, Inc.2025-07-31